Avet Pharmaceuticals Inc. Since its establishment in 2006, Avet has been dedicated to the acquisition, licensing, development, marketing, sale, and distribution of generic and legacy branded pharmaceutical products in the U. S.

With a diverse range of products available in multiple pack sizes, Avet focuses on therapeutic categories such as cardiovascular, metabolic disease, anti-infective, and pain management. Avet's business model is built upon a globally integrated supply network, which allows them to leverage strategic outsourcing to U. S.

F. D. A.

This network enables Avet to maintain a robust pipeline of multisource and high barrier products, with constant introduction of new generic products as they go through the regulatory approval cycle. What sets Avet apart is their commitment to quality and flexibility. Their strong commercial operations and sales team work seamlessly with their global supply chain network, providing access to low-cost development, materials, and manufacturing capacity.

This integration allows Avet to excel in business development while focusing on commercialization excellence and customer service